virus
respons
great
major
lower
respiratori
tract
infect
lrti
respiratori
syncyti
viru
common
viru
caus
lrti
hospitalis
children
highest
rate
hospitalis
due
respiratori
diseas
new
zealand
hospit
higher
proport
children
antibiot
discontinu
influenza
identifi
nasopharyng
swab
compar
virusesa
high
proport
children
admit
lrti
antibiot
continu
beyond
discharg
even
viral
aetiolog
highli
children
present
lrti
np
sampl
taken
least
one
viral
pathogen
identifi
develop
multiplex
polymeras
chain
reaction
pcr
assay
allow
clinician
identifi
larg
rang
virus
pathogen
children
lower
respiratori
tract
infect
lrti
one
virus
identifi
children
admit
hospit
radiolog
proven
lrti
recent
studi
usa
respiratori
syncyti
viru
rsv
commonli
interpret
pcr
result
nasopharyng
sampl
challeng
howev
virus
frequent
identifi
upper
airway
asymptomat
infecti
diseas
societi
america
idsa
guidelin
manag
pneumonia
cap
recommend
antimicrobi
therapi
routin
requir
age
children
cap
viral
pathogen
respons
great
major
clinic
diseas
addit
state
antibacteri
therapi
necessari
children
either
outpati
inpati
posit
test
influenza
viru
absenc
clinic
laboratori
radiolog
find
suggest
bacteri
coinfect
new
zealand
children
shown
highest
rate
hospitalis
due
respiratori
studi
aim
describ
usag
multiplex
pcr
nasopharyng
swab
np
sampl
children
present
lrti
winter
month
hospit
particular
emphasi
impact
use
antibiot
empir
discharg
christchurch
hospit
largest
hospit
south
island
new
zealand
provid
tertiari
level
paediatr
care
children
commun
lrti
may
admit
care
gener
pediatrician
either
refer
gener
practition
emerg
depart
antibiot
depart
lrti
children
year
age
either
oral
amoxycillin
intraven
penicillin
children
age
month
year
admit
hospit
winter
month
junejulyaugust
diagnosi
lrti
includ
studi
children
identifi
discharg
code
code
discharg
letter
patient
review
confirm
diagnosi
radiolog
confirm
requir
winter
month
pcr
respiratori
viru
test
avail
daili
includ
weekend
sampl
arriv
laboratori
morn
result
gener
avail
pm
canterburi
health
laboratori
use
diagnost
kit
multiplex
test
follow
organ
adenoviru
bocaviru
coronavirus
human
metapneumoviru
hmpv
influenza
virus
b
parainfluenza
virus
picornaviru
rsv
mycoplasma
pneumonia
purpos
studi
children
multipl
virus
detect
classifi
firstli
accord
whether
influenza
viru
infect
treatment
avail
without
influenza
categoris
per
rhedin
et
either
rsvhmpvparainfluenza
rhinovirusbocaviruscoronaviru
primari
infect
order
prefer
minimum
length
stay
specifi
children
evalu
discharg
day
includ
analysi
length
stay
calcul
day
children
code
bronchiol
clinic
descript
fit
bronchiol
note
exclud
along
children
immunocompromis
cystic
fibrosi
readmiss
occur
within
week
previou
admiss
lrti
exclud
clinic
note
laboratori
record
review
child
determin
treatment
investig
child
receiv
use
empir
antibiot
record
well
whether
antibiot
stop
discharg
continu
commun
total
length
antibiot
prescrib
individu
children
discharg
abl
determin
conting
tabl
analysi
use
compar
proport
children
specif
outcom
test
probabl
valu
consid
statist
signific
two
hundr
children
lrti
admit
winter
month
averag
length
stay
day
hospit
day
less
mean
age
children
month
children
new
zealand
european
maori
pacif
island
decent
np
sampl
obtain
admiss
children
part
initi
investig
least
one
pathogen
detect
multiplex
pcr
test
children
either
influenza
b
detect
one
either
rsvhmpvparainfluenza
viru
significantli
larger
proport
children
np
sampl
taken
receiv
empir
antibiot
compar
children
sampl
taken
p
np
sampl
taken
antibiot
discontinu
prior
time
discharg
compar
np
sampl
p
tabl
show
antimicrobi
manag
use
children
np
relat
np
result
children
influenza
detect
like
treat
oseltamivir
also
like
receiv
antibiot
antibiot
discontinu
prior
discharg
small
proport
children
virus
identifi
antibiot
discontinu
total
children
admiss
last
h
subgroup
np
sampl
taken
compar
children
admit
shorter
time
period
children
np
receiv
antibiot
admiss
compar
np
admiss
p
children
studi
month
readmit
follow
discharg
lrti
children
hospit
admit
lrti
commonli
np
sampl
taken
studi
subsequ
influenza
identifi
significantli
like
receiv
antibiot
antibiot
stop
prior
discharg
howev
substanti
proport
continu
antibiot
even
influenza
identifi
also
appear
clinician
reluct
stop
antibiot
prior
discharg
children
virus
identifi
even
provid
plausibl
aetiolog
explan
child
lrti
view
repres
miss
opportun
antimicrobi
stewardship
mani
children
receiv
cours
antibiot
long
rhedin
et
recent
report
children
acut
respiratori
tract
infect
hmpv
parainfluenza
virus
rsv
highli
children
respiratori
tract
symptom
compar
asymptomat
control
suggest
child
compat
symptom
sign
like
caus
lrti
associ
less
certain
virus
human
rhinoviru
adenovirus
human
bocaviru
human
coronavirus
popul
children
rsv
hmpv
parainfluenza
virus
almost
uniformli
antibiot
continu
beyond
day
overal
proport
children
popul
antibiot
stop
follow
receipt
multiplex
pcr
test
result
low
np
child
invas
test
perform
multiplex
pcr
routin
common
clinic
present
may
expens
benefit
includ
better
understand
chang
preval
particular
virus
lrti
commun
abil
provid
definit
inform
parent
aetiolog
child
infect
potenti
reduc
amount
antibiot
children
receiv
hospit
obtain
np
sampl
ad
valuabl
inform
clinician
use
effect
antimicrobi
stewardship
evid
suggest
children
virus
import
aetiolog
major
idsa
guidelin
clearli
tri
direct
clinician
away
use
antibiot
empir
popul
mani
clinician
may
feel
uncomfort
prescrib
antibiot
children
lrti
particularli
sever
enough
need
hospitalis
start
empir
antibiot
routin
diagnost
test
bacteri
infect
lower
respiratori
tract
limit
insensit
young
children
may
contribut
practic
howev
make
sens
stop
antibiot
clinic
present
consist
infect
viru
identifi
np
sampl
studi
multiplex
pcr
use
detect
pathogen
rapid
test
influenza
use
would
differ
time
result
explain
discrep
rate
antibiot
prescrib
children
influenza
pathogen
proport
children
pcr
test
result
avail
prior
discharg
unknown
difficult
know
contribut
ongo
use
antibiot
follow
discharg
ensur
np
result
avail
rapidli
essenti
part
antimicrobi
stewardship
programm
retrospect
natur
studi
meant
unabl
determin
decis
make
process
involv
prescript
empir
antibiot
equal
decis
around
stop
antibiot
seldom
document
adequ
possibl
aspect
clinician
prefer
belief
may
contribut
significantli
outcom
beyond
scope
studi
like
determin
effect
antimicrobi
stewardship
involv
choos
appropri
antibiot
also
ensur
antibiot
stop
requir
identifi
cohort
children
signific
respiratori
diseas
molecular
diagnost
techniqu
frequent
use
diagnos
viral
infect
hospit
introduct
routin
diagnost
paradigm
unfortun
accompani
chang
clinic
practic
includ
earli
cessat
antibiot
next
challeng
educ
clinician
encourag
stop
antibiot
earli
children
lrti
clinic
compat
viral
pathogen
detect
